ROBY ANTONY: Open Payments
NPI 1447624838 · FLORAL PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$331 in 16 payments from 7 companies in 2025. Trend: 2023 $212 · 2024 $181 · 2025 $331
Food & beverage: $331
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $108 |
| Novo Nordisk Inc | 3 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| Recor Medical Inc | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: REPATHA, Kerendia, LEQVIO, Wegovy, Paradise Ultrasound Renal Denervation System, Ozempic, Rybelsus, NEXLIZET.
Industry payments across NY — which companies pay providers there.
